ASEAN Rabies Veterinary Vaccines Market Size, Share & Trends Analysis Report By Application (Companion Animals, Livestock Animals), By Distribution Channel, By Country, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The ASEAN rabies veterinary vaccines market size was estimated at USD 31.71 million in 2024 and is projected to grow at a CAGR of 6.73% from 2025 to 2030. Some of the key drivers fueling market growth are increased dog population in several countries in Asia, rising zoonosis concerns, and government initiatives to eliminate rabies, and strategic initiatives by key market players and veterinary care providers. For instance, according to the article released in September 2024, by World Health Organization (WHO) and Food and Agriculture Organization of the United Nations (FAO) together are taking actions to prevent animal deaths in Indonesia. These initiatives include mass dog vaccination, integrated bite case management, and others which further increase the demand for vaccine and thus, driving the market growth.

In Southeast Asian developing countries, where stray dogs and cats are common, rabies is still a big threat. Dog influenza is thought to be prevalent in Southeast Asian nations like Indonesia, the Philippines, Thailand, Myanmar, Vietnam, Cambodia, and Laos. Rabies is a disease that both humans and animals must report in many of these nations. The Association of Southeast Asian Nations, or ASEAN, is collaborating with other animal healthcare groups to eradicate rabies in ASEAN nations by 2030 in response to the current pandemic situation.

Moreover, the rising pet ownership rates in the region have contributed to the market expansion, as there is growing awareness among pet owners to vaccinate their animals against diseases. The growing urbanization and expansion of livestock farming in developing countries also fuel the demand for vaccines. Worldwide, it has been stated that the achievement of 70% dog vaccination coverage would bring human rabies cases under control. Vaccinating dogs is thought to be the most effective technique for controlling, preventing, and eradicating rabies in these nations. Hence, companies such as Boehringer collaborates with GARC, a Global Alliance for Rabies Control to offer workshops, surveillance, and support animal vaccination programs.

Market Concentration & Characteristics

The market is considered to be at a medium level in terms of growth stage, with significant market growth. The market is growing owing to several initiatives and collaborations undertaken by key players in the animal health industry. The use of vaccine in veterinary medicine has increased significantly in recent years which is attributed to increasing awareness about zoonotic diseases and multiple vaccination programs.

The market demonstrates a moderate to high degree of innovation. For instance, Cadila Pharmaceuticals won theprestigious India Pharma World Awards in 2023 for its breakthrough three-dose veterinary rabies vaccine, “ThRabis”. Many vaccines need five doses and many times this course remains incomplete and prevents the patient from being protected by rabies. It is a recombinant nanoparticle-based rabies G protein vaccine that provides a more convenient regimen. These important developments and innovations boost the growth of the ASEAN veterinary rabies vaccines industry.

The market sees a high degree of merger and acquisition activity, indicating consolidation and strategic collaboration among industry leaders. These transactions are typically driven by the need to reach a larger demographic, obtain access to healthcare facilities, and achieve prevention of large groups along with economic benefits.

The ASEAN rabies veterinary vaccines industry is shaped by various regulatory frameworks aimed at ensuring the safety and efficacy of these formulations for animal treatment. In some countries, veterinary boards or councils establish additional guidelines around the use of veterinary vaccines, including practitioner certification and training requirements. These guidelines help ensure that veterinary professionals have adequate knowledge to vaccinate effectively.

There are several type of veterinary rabies vaccine including oral formulations, intradermal injections, etc. There is no specific substitute for such vaccines other than post infection treatment. Due to the lack of alternatives for the product, the market is expected to retain its position and grow steadily in the forecast period.

Moderate levels of regional growth operations in the market are caused by initiatives by major competitors in the market and government support. For instance, as per the news published in August 2023, Australia supported Indonesian animal health market with 4,00,000 rabies vaccines in order to control the spread of rabies. Such collaborations among different countries lead to significant market expansion in the ASEAN region.

Application Insights

Companion animals accounted for the largest revenue share of over 95.0% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This is due to the increasing trend of pet ownership, especially in ASAEN countries. Increasing disposable incomes in developing countries have fueled the demand for preventive healthcare in pets, including vaccinations. Urbanization and the expansion of veterinary clinics have made vaccination services more accessible, contributing to the rapid adoption of vaccines.

Moreover, awareness campaigns highlighting the risks of rabies transmission from companion animals to humans have spurred pet owners to prioritize regular vaccinations. Governments and NGOs are also focusing on controlling rabies through mandatory pet vaccination laws, which has further boosted the segment growth. Additionally, companies that offer rabies vaccines for livestock animals, like BroadChem Philippines Biopharma Corporation and Zoetis, are able to maintain a competitive market position. For example, BroadChem Philippines Biopharma Corporation offers Biocan R vaccine for sheep, goats, pigs, and cattle, while Zoetis offers VANGUARD RABIES 1/3-year vaccine for cattle.

Distribution Channel Insights

The hospital/clinical pharmacy segment accounted for the largest revenue share of over 45.0% in 2024. This is due to their ability to maintain stringent standards to store animal vaccines and assist in administering for efficient results. These pharmacies also serve as key centres for sourcing veterinary vaccines, particularly in areas where veterinary services are concentrated. In addition, the collaboration of veterinary professionals with hospitals and clinical pharmacies enhances trust and reliability which further fosters rate of adoption of such vaccines among pet owners and livestock farmers.

The e-commerce segment is anticipated to grow at the fastest CAGR over the forecast period. This growth is attributed to the increasing trend of digital platforms and their adoption among people due to their convenience. Online stores or channels enhance the accessibility of consumers to a wide range of animal vaccines and their competitive prices which gives them an edge over traditional purchasing. Moreover, as e-commerce sector supports last-mile delivery, making vaccines accessible in remote areas, it is increasingly preferred in recent years and is expected to increase in the coming years, thus boosting the segment growth.

Country Insights

Thailand ASEAN Rabies Veterinary Vaccines Market Trends

The Thailand market is anticipated to grow at a significant CAGR over the forecast period. Thailand has made significant strides in controlling rabies through extensive vaccination programs for domestic animals and stray dogs, supported by government initiatives such as the National Strategic Plan for Rabies Elimination. The country organizes campaigns on every World Rabies Day to educate people about dangers and treatment of rabies. The government aims to free the country from rabies by 2025. Thus, the veterinary rabies vaccines market is driven by its strong focus on rabies eradication and well-established veterinary infrastructure.

Key ASEAN Rabies Veterinary Vaccines Company Insights

The existence of numerous small, medium, and large businesses characterizes the competitive and fragmented market. To increase their market share, the market participants implement strategic initiatives such product enhancements, regional growth, distribution alliances, partnerships, and mergers and acquisitions. For instance, in April 2022, as part of its commitment to sustainable development, Boehringer Ingelheim organized multiple rabies vaccination initiatives across Asia in the year 2022 as part of their commitment to sustainable development. The company aims to vaccinate 12,000 animals across Malaysia, the Philippines, Indonesia, and Vietnam.

Recent Developments

• In June 2024, LakeShore Biopharma Co., Ltd. announced positive results for phase III clinical trial of next-generation PIKA rabies vaccine to fulfill the vision of one week vaccine regimen for rabies. 

• In April 2024, Beijing Small Animal Diagnosis and Treatment Industry Association collaborated with Merck Animal Health Products (Shanghai) Co., Ltd. and Ruipai Pet Hospital to officially launch Beijing 2024 CRC Rabies Prevention and Control Project.

ASEAN Rabies Veterinary Vaccines Market Report Scope

ASEAN Rabies Veterinary Vaccines Market Report Segmentation

This report forecasts revenue growth at regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the ASEAN rabies veterinary vaccines market report based on application, distribution channel, and country:

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Companion Animals

  • Livestock Animals

• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Retail

  • E-Commerce

  • Hospital/Clinical Pharmacy

• Country Outlook (Revenue, USD Million, 2018 - 2030)

  • Indonesia

  • Vietnam

  • Myanmar

  • Malaysia

  • Thailand

  • Philippines

  • Laos

  • Cambodia

  • Rest of ASEAN